[1]
Jansen J.A., Vehof J.W.M., Ruhé P.Q., Kroeze-Deutman H., Kuboki Y., Takita H., Hedberg E.L. and Mikos A.G. J Control Release, 2005 101(1-3):127-36.
DOI: 10.1016/j.jconrel.2004.07.005
Google Scholar
[2]
Hollinger J.O., Leong K., Biomaterials, 1996; 17:187-194.
Google Scholar
[3]
Ono I., Gunji H, Kaneko F., Saito T., and Kuboki Y. J Craniofac Surg, 1995; 6(3):238-44.
Google Scholar
[4]
Kirker-Head C.A. Adv Drug Deliv Rev, 2000; 43:65
Google Scholar
[5]
Liu Y., Hunziker E. B., de Groot K., Bone, 2005; 36: 745-757.
Google Scholar
[6]
Liu Y., Hunziker E. B., Van de Vaal C., de Groot K., Bioceramics, 2003; 16: 619-622. 0 2 4 6 8 10 12 14 16 18
Google Scholar
[2]
5µg 5.0µg 7.5µg Amount of BMP-2 adsorbed (µg/implant) 1 week 2 weeks 3 weeks
Google Scholar